DR BURNS: Ms
Q is a 64-year-old woman with a history of mild hypercalcemia and hyperparathyroidism.
She has managed care insurance.
Ms Q states that on a routine blood test 7 years ago she was noted to
have a calcium level of 10.1 mg/dL (2.5 mmol/L). She has subsequently had
her calcium checked on a biannual basis and it has ranged from 10.4 to 11.3
mg/dL (2.6-2.8 mmol/L). Ms Q was referred to an endocrinologist in December
2002 after her calcium was higher than 11 mg/dL (2.7 mmol/L) on 3 occasions.
Her laboratory studies just prior to her visit revealed a calcium level of
11.1 mg/dL (2.8 mmol/L), a parathyroid hormone (PTH) level of 102 pg/mL, and
a phosphate level of 3.4 mg/dL.
A, The normal feedback relationship between calcium and parathyroid
hormone is shown. Parathyroid hormone is suppressed by calcium over the normal
range for serum calcium (shaded area), with the set point for calcium at the
midpoint of the curve. In all forms of hyperparathyroidism the adenoma is
relatively insensitive to feedback suppression by calcium. This results in
a shift to the right in the feedback relationship and an increase in the set
point for serum calcium. B, An increase in the set point for serum calcium
is a determinant of parathyroid adenoma growth. The adenoma size increases
until it reaches a sufficient size to maintain parathyroid hormone and serum
calcium at the new set point, and the adenoma then stops growing.
A, In the early phase, sestamibi is taken up by thyroid tissue (black
arrowheads) and parathyroid (yellow arrowhead). B, Parathyroid uptake persists
at a later time (yellow arrowhead).
Thank you for submitting a comment on this article. It will be reviewed by JAMA editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 5
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.